Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS-Reference-Cited by-同舟云学术

Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS

Published:2005-01-03 Issue:1 Volume:115 Page:187-194
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Villar Luisa M.,Sádaba María C.,Roldán Ernesto,Masjuan Jaime,González-Porqué Pedro,Villarrubia Noelia,Espiño Mercedes,García-Trujillo José A.,Bootello Alfredo,Álvarez-Cermeño José C.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference39 articles.

1. Remembering MOG: Autoantibody mediated demyelination in multiple sclerosis?

2. The role of B cells and autoantibodies in multiple sclerosis

3. Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response

4. B cells and antibodies in CNS demyelinating disease

5. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination

Cited by 189 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fluid biomarkers in multiple sclerosis: from current to future applications;The Lancet Regional Health - Europe;2024-09

2. Multiple Sclerosis and Clostridium perfringens Epsilon Toxin: Is There a Relationship?;Biomedicines;2024-06-23

3. The role of oligoclonal band count and IgG index in treatment response and disease activity in multiple sclerosis;Multiple Sclerosis and Related Disorders;2024-03

4. The elusive nature of the oligoclonal bands in multiple sclerosis;Journal of Neurology;2023-11-09

5. Is it cost-effective to request IgM oligoclonal bands against lipids in daily practice as a biomarker for poor prognosis in multiple sclerosis?;Multiple Sclerosis and Related Disorders;2023-11